Developing New Therapies for Spinal Cord Injury

 

In the early 1980s, Prof. Michal Schwartz, an immunologist, started to explore the cross-talk between the immune and nervous systems.

 

 

New therapies for spinal cord injury based on original concepts proposed by Schwartz are being developed and tested in clinical trials by Proneuron, a company in Kiryat Weizmann.